{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T08:10:18Z","timestamp":1794384618580,"version":"4.9.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T00:00:00Z","timestamp":1563494400000},"content-version":"vor","delay-in-days":383,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science KAKENHI","doi-asserted-by":"publisher","award":["JP17H04085"],"award-info":[{"award-number":["JP17H04085"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science KAKENHI","doi-asserted-by":"publisher","award":["JP66KT0111"],"award-info":[{"award-number":["JP66KT0111"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"JST CREST program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Program on the Innovative Development and the Application of New Drugs for Hepatitis B","award":["JP17fk0310103j0001"],"award-info":[{"award-number":["JP17fk0310103j0001"]}]},{"name":"Program on the Innovative Development and the Application of New Drugs for Hepatitis B","award":["JP17fk0310114j0001"],"award-info":[{"award-number":["JP17fk0310114j0001"]}]},{"name":"Program on the Innovative Development and the Application of New Drugs for Hepatitis B","award":["JP17fk0310101j1001"],"award-info":[{"award-number":["JP17fk0310101j1001"]}]},{"name":"Japanese Initiative for Progress of Research on Infectious Disease for global Epidemic","award":["JP17fm0208019j0001"],"award-info":[{"award-number":["JP17fm0208019j0001"]}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Pharmacological Research Foundation, Tokyo"},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"JST CREST","doi-asserted-by":"publisher","award":["JPMJCR12L2"],"award-info":[{"award-number":["JPMJCR12L2"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Chemical Biology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.chembiol.2018.04.011","type":"journal-article","created":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T10:53:47Z","timestamp":1526554427000},"page":"906-915.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["De Novo Macrocyclic Peptide Inhibitors of Hepatitis B Virus Cellular Entry"],"prefix":"10.1016","volume":"25","author":[{"given":"Toby","family":"Passioura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Watashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kento","family":"Fukano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satomi","family":"Shimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wakana","family":"Saso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Morishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Ogasawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhito","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Mizokami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Sureau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Suga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaji","family":"Wakita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chembiol.2018.04.011_bib1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00424-013-1367-0","article-title":"Sodium-dependent bile salt transporters of the SLC10A transporter family: more than solute transporters","volume":"466","author":"Anwer","year":"2014","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.chembiol.2018.04.011_bib2","doi-asserted-by":"crossref","first-page":"9786","DOI":"10.1128\/JVI.79.15.9786-9798.2005","article-title":"Mapping of the hepatitis B virus pre-S1 domain involved in receptor recognition","volume":"79","author":"Barrera","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chembiol.2018.04.011_bib3","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1084\/jem.20021756","article-title":"Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes","volume":"197","author":"Bartosch","year":"2003","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.chembiol.2018.04.011_bib4","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/cpt.744","article-title":"The NTCP-inhibitor myrcludex B: effects on bile acid disposition and tenofovir pharmacokinetics","volume":"103","author":"Blank","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.chembiol.2018.04.011_bib5","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.jhep.2014.05.016","article-title":"Bridging basic science and clinical research: the EASL monothematic conference on translational Research in viral hepatitis","volume":"61","author":"Boettler","year":"2014","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.chembiol.2018.04.011_bib6","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jhep.2016.04.016","article-title":"Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: first results of a phase Ib\/IIa study","volume":"65","author":"Bogomolov","year":"2016","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.chembiol.2018.04.011_bib7","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1053\/j.gastro.2005.03.090","article-title":"Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes","volume":"129","author":"Glebe","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.chembiol.2018.04.011_bib8","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/nprot.2011.331","article-title":"Flexizymes for genetic code reprogramming","volume":"6","author":"Goto","year":"2011","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.chembiol.2018.04.011_bib9","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1128\/JVI.79.3.1613-1622.2005","article-title":"Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein","volume":"79","author":"Gripon","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chembiol.2018.04.011_bib10","doi-asserted-by":"crossref","first-page":"10629","DOI":"10.1073\/pnas.88.23.10629","article-title":"Functional expression cloning and characterization of the hepatocyte Na+\/bile acid cotransport system","volume":"88","author":"Hagenbuch","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chembiol.2018.04.011_bib11","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1021\/cb200388k","article-title":"In\u00a0vitro selection of anti-Akt2 thioether-macrocyclic peptides leading to isoform-selective inhibitors","volume":"7","author":"Hayashi","year":"2012","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.chembiol.2018.04.011_bib12","doi-asserted-by":"crossref","first-page":"10514","DOI":"10.3390\/molecules180910514","article-title":"A macrocyclic peptide that serves as a cocrystallization ligand and inhibits the function of a MATE family transporter","volume":"18","author":"Hipolito","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.chembiol.2018.04.011_bib13","doi-asserted-by":"crossref","first-page":"6373","DOI":"10.1038\/ncomms7373","article-title":"Artificial human Met agonists based on macrocycle scaffolds","volume":"6","author":"Ito","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chembiol.2018.04.011_bib14","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.bbrc.2013.12.052","article-title":"Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP","volume":"443","author":"Iwamoto","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.chembiol.2018.04.011_bib15","doi-asserted-by":"crossref","first-page":"11945","DOI":"10.1128\/JVI.01855-15","article-title":"A novel tricyclic polyketide, vanitaracin a, specifically inhibits the entry of hepatitis B and D Viruses by targeting sodium taurocholate cotransporting polypeptide","volume":"89","author":"Kaneko","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chembiol.2018.04.011_bib16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.chembiol.2007.12.008","article-title":"Messenger RNA-programmed incorporation of multiple N-methyl-amino acids into linear and cyclic peptides","volume":"15","author":"Kawakami","year":"2008","journal-title":"Chem. Biol."},{"key":"10.1016\/j.chembiol.2018.04.011_bib17","doi-asserted-by":"crossref","first-page":"14773","DOI":"10.1038\/ncomms14773","article-title":"Highly selective inhibition of histone demethylases by de novo macrocyclic peptides","volume":"8","author":"Kawamura","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chembiol.2018.04.011_bib18","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jhep.2014.05.018","article-title":"Kinetics of the bile acid transporter and hepatitis B virus receptor Na+\/taurocholate\u00a0cotransporting polypeptide (NTCP) in hepatocytes","volume":"61","author":"Konig","year":"2014","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.chembiol.2018.04.011_bib19","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1128\/JVI.73.3.2052-2057.1999","article-title":"Infection process of the hepatitis B virus depends on the presence of a defined sequence in the pre-S1 domain","volume":"73","author":"Le Seyec","year":"1999","journal-title":"J.\u00a0Virol."},{"issue":"Suppl 3","key":"10.1016\/j.chembiol.2018.04.011_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3851\/IMP1619","article-title":"Molecular genetics of HBV infection","volume":"15","author":"Locarnini","year":"2010","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.chembiol.2018.04.011_bib21","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1002\/anie.201108118","article-title":"Discovery of macrocyclic peptides armed with a mechanism-based warhead: isoform-selective inhibition of human deacetylase SIRT2","volume":"51","author":"Morimoto","year":"2012","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.chembiol.2018.04.011_bib22","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.bbrc.2013.09.100","article-title":"Specific inhibition of hepatitis C virus entry into host hepatocytes by fungi-derived sulochrin and its derivatives","volume":"440","author":"Nakajima","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.chembiol.2018.04.011_bib23","doi-asserted-by":"crossref","first-page":"9058","DOI":"10.1128\/JVI.00856-16","article-title":"Fungus-derived neoechinulin B as a novel antagonist of liver X receptor, identified by chemical genetics using a hepatitis C virus cell culture system","volume":"90","author":"Nakajima","year":"2016","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chembiol.2018.04.011_bib24","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1053\/j.gastro.2013.12.024","article-title":"Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes","volume":"146","author":"Ni","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.chembiol.2018.04.011_bib25","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jhep.2013.11.022","article-title":"Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor","volume":"60","author":"Nkongolo","year":"2014","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.chembiol.2018.04.011_bib26","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.bbrc.2014.08.029","article-title":"Formation of covalently closed circular DNA in Hep38.7-Tet cells, a tetracycline inducible hepatitis B virus expression cell line","volume":"452","author":"Ogura","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.chembiol.2018.04.011_bib27","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.vaccine.2011.12.116","article-title":"Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity","volume":"30","author":"Ott","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.chembiol.2018.04.011_bib28","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1146\/annurev-biochem-060713-035456","article-title":"Selection-based discovery of druglike macrocyclic peptides","volume":"83","author":"Passioura","year":"2014","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.chembiol.2018.04.011_bib29","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1053\/j.gastro.2007.11.036","article-title":"Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach","volume":"134","author":"Pawlotsky","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.chembiol.2018.04.011_bib30","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/hep.27608","article-title":"The p.Ser267Phe variant in SLC10A1 is associated with resistance to chronic hepatitis B","volume":"61","author":"Peng","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.chembiol.2018.04.011_bib31","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nbt1389","article-title":"Prevention of hepatitis B virus infection in\u00a0vivo by entry inhibitors derived from the large envelope protein","volume":"26","author":"Petersen","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.chembiol.2018.04.011_bib32","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jhep.2016.11.009","article-title":"Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activity","volume":"66","author":"Shimura","year":"2017","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.chembiol.2018.04.011_bib33","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/hep.27694","article-title":"Impaired uptake of conjugated bile acids and hepatitis B virus pres1-binding in Na(+)-taurocholate cotransporting polypeptide knockout mice","volume":"62","author":"Slijepcevic","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.chembiol.2018.04.011_bib34","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/hep.21345","article-title":"Influence of hepatitis B virus genotypes on the intra- and extracellular expression of viral DNA and antigens","volume":"44","author":"Sugiyama","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.chembiol.2018.04.011_bib35","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature12014","article-title":"Structural basis for the drug extrusion mechanism by a MATE multidrug transporter","volume":"496","author":"Tanaka","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.chembiol.2018.04.011_bib36","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/hep.28952","article-title":"A new class of hepatitis B and D virus entry inhibitors, proanthocyanidin and its analogs, that directly act on the viral large surface proteins","volume":"65","author":"Tsukuda","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.chembiol.2018.04.011_bib37","doi-asserted-by":"crossref","first-page":"5673","DOI":"10.1074\/jbc.M114.602540","article-title":"Dysregulation of retinoic acid receptor diminishes hepatocyte permissiveness to hepatitis B virus infection through modulation of sodium taurocholate cotransporting polypeptide (NTCP) expression","volume":"290","author":"Tsukuda","year":"2015","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2018.04.011_bib38","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/hep.27240","article-title":"Sodium taurocholate cotransporting polypeptide (SLC10A1) deficiency: conjugated hypercholanemia without a clear clinical phenotype","volume":"61","author":"Vaz","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.chembiol.2018.04.011_bib39","doi-asserted-by":"crossref","first-page":"e0117152","DOI":"10.1371\/journal.pone.0117152","article-title":"Primary biliary acids inhibit hepatitis D virus (HDV) entry into human hepatoma cells expressing the sodium-taurocholate cotransporting polypeptide (NTCP)","volume":"10","author":"Veloso Alves Pereira","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.chembiol.2018.04.011_bib40","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jhep.2016.11.028","article-title":"Advancing hepatitis B virus entry inhibitors","volume":"66","author":"Verrier","year":"2017","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.chembiol.2018.04.011_bib41","doi-asserted-by":"crossref","first-page":"31715","DOI":"10.1074\/jbc.M113.501122","article-title":"Interleukin-1 and tumor necrosis factor-alpha trigger restriction of hepatitis B virus infection via a cytidine deaminase activation-induced cytidine deaminase (AID)","volume":"288","author":"Watashi","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.chembiol.2018.04.011_bib42","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1002\/hep.26982","article-title":"Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP)","volume":"59","author":"Watashi","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.chembiol.2018.04.011_bib43","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.chembiol.2011.09.013","article-title":"Natural product-like macrocyclic N-methyl-peptide inhibitors against a ubiquitin ligase uncovered from a ribosome-expressed de novo library","volume":"18","author":"Yamagishi","year":"2011","journal-title":"Chem. Biol."},{"key":"10.1016\/j.chembiol.2018.04.011_bib44","doi-asserted-by":"crossref","first-page":"7977","DOI":"10.1128\/JVI.03540-12","article-title":"Molecular determinants of hepatitis B and D virus entry restriction in mouse sodium taurocholate cotransporting polypeptide","volume":"87","author":"Yan","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chembiol.2018.04.011_bib45","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1128\/JVI.03478-13","article-title":"Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide","volume":"88","author":"Yan","year":"2014","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.chembiol.2018.04.011_bib46","doi-asserted-by":"crossref","first-page":"e00049","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"Elife"},{"key":"10.1016\/j.chembiol.2018.04.011_bib47","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1136\/gutjnl-2014-308943","article-title":"Towards an HBV cure: state-of-the-art and unresolved questions \u2013 report of the ANRS workshop on HBV cure","volume":"64","author":"Zeisel","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.chembiol.2018.04.011_bib48","doi-asserted-by":"crossref","first-page":"9294","DOI":"10.1073\/pnas.0503596102","article-title":"Robust hepatitis C virus infection in\u00a0vitro","volume":"102","author":"Zhong","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Cell Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945618301259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451945618301259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T14:33:03Z","timestamp":1762525983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451945618301259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":48,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S2451945618301259"],"URL":"https:\/\/doi.org\/10.1016\/j.chembiol.2018.04.011","relation":{},"ISSN":["2451-9456"],"issn-type":[{"value":"2451-9456","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"De Novo Macrocyclic Peptide Inhibitors of Hepatitis B Virus Cellular Entry","name":"articletitle","label":"Article Title"},{"value":"Cell Chemical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chembiol.2018.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}